Streamlining Research on Controlled Substances Act of 2021
Official title: To amend the Controlled Substances Act to improve the process for conducting scientific research on schedule I controlled substances, and for other purposes.
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
Streamlining Research on Controlled Substances Act of 2021
This bill makes changes to the registration process for conducting research on controlled substances that are included in schedule I of the Controlled Substances Act.
Among the changes, the bill does the following:
- exempts from the registration requirements an agent or employee of a registered researcher,
- permits a single registration for contiguous research sites, and
- requires the Drug Enforcement Administration and the Department of Health and Human Services to review and issue guidance on the processes to obtain or modify federal authorization to conduct research with controlled substances.
- Introduced in House Formatted Text PDF Formatted XML
Cite this page
U.S. Congress. (2026). H.R. 2405: Streamlining Research on Controlled Substances Act of 2021. 117th Congress. Open America. https://openamerica.io/bill/117-HR-2405/
"H.R. 2405: Streamlining Research on Controlled Substances Act of 2021." 117th Congress, 2026, Open America, https://openamerica.io/bill/117-HR-2405/.
H.R. 2405, 117th Cong. (2026), https://openamerica.io/bill/117-HR-2405/.
[H.R. 2405: Streamlining Research on Controlled Substances Act of 2021](https://openamerica.io/bill/117-HR-2405/)